Home  >  Products  >  ARG2 (arginase, type II) Blocking Peptide (the N terminal of ARG2)(100ug)
ARG2 (arginase, type II) Blocking Peptide (the N terminal of ARG2)(100ug)

ARG2 (arginase, type II) Blocking Peptide (the N terminal of ARG2)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ARG2 Antibody(ARP54566_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP54566
Size: 100ug
Weight: 36kDa
Gene: 384
Format: Lyophilized powder
Target: Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. ARG2 (type II isoform) is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood; it is thought to play a role in nitric oxide and polyamine metabolism.